Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors

Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors

Article Source: Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors 
Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, et al. (2017) Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors. PLOS Medicine 14(6): e1002315. https://doi.org/10.1371/journal.pmed.1002315

 

“… ICMJE will require the following as conditions of consideration for publication of a clinical trial report in our member journals:

  1. As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of clinical trials must contain a data sharing statement as described below.
  2. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial’s registration. The ICMJE’s policy regarding trial registration is explained at www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.

Data sharing statements must indicate the following: whether individual deidentified participant data (including data dictionaries) will be shared; what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses and by what mechanism). Illustrative examples of data sharing statements that would meet these requirements are in Table 1.”

journal.pmed.1002315.t001

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

>

Download here

>
screenshot

What are preprints? Α video by ASAPbio

Learn more at http://asapbio.org
Preprints are a way in which a manuscript containing scientific results can be rapidly communicated from one scientist, or a a group of scientists, to the entire scientific community. This video by ASAPbio (Accelerating Science and Publication in biology) explains what preprints are and their benefits, how they differ from journal publications, and how scientists can use both mechanisms to communicate their work.

How British and American Spelling Parted Ways

“A history of the evolution of guidelines for reporting medical research” by Altman DG and Simera I (2015)

Altman DG, Simera I (2015). A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network.

read more here

“Concern about the quality of medical research has been expressed intermittently over a century, and quality about reports of research for almost as long. At last, in the 1990s, serious international efforts began to promote better reporting of medical research. The emergence of the EQUATOR Network has been both a result and a cause of the progress that is being made.

This James Lind Library article has been republished in the Journal of the Royal Society of Medicine 2016;109:67-77  “

Powered by Netfirms